nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—SLC15A2—melanoma	0.81	1	CbGaD
Fosinopril—ACE—umbilical vein—melanoma	0.00643	0.164	CbGeAlD
Fosinopril—ACE—hindlimb—melanoma	0.00588	0.15	CbGeAlD
Fosinopril—ACE—arm—melanoma	0.00562	0.143	CbGeAlD
Fosinopril—ACE—appendage—melanoma	0.00505	0.129	CbGeAlD
Fosinopril—ACE—endothelium—melanoma	0.00305	0.0778	CbGeAlD
Fosinopril—ACE—blood vessel—melanoma	0.00281	0.0717	CbGeAlD
Fosinopril—ACE—neck—melanoma	0.00201	0.0513	CbGeAlD
Fosinopril—SLC15A1—mammalian vulva—melanoma	0.00165	0.0422	CbGeAlD
Fosinopril—ACE—eye—melanoma	0.00149	0.0382	CbGeAlD
Fosinopril—Spirapril—SLC15A2—melanoma	0.00139	0.216	CrCbGaD
Fosinopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00136	0.379	CbGpPWpGaD
Fosinopril—SLC15A2—retina—melanoma	0.00129	0.033	CbGeAlD
Fosinopril—Cilazapril—SLC15A2—melanoma	0.00124	0.193	CrCbGaD
Fosinopril—Trandolapril—SLC15A2—melanoma	0.0012	0.187	CrCbGaD
Fosinopril—Ramipril—SLC15A2—melanoma	0.0012	0.187	CrCbGaD
Fosinopril—ACE—mammalian vulva—melanoma	0.00119	0.0303	CbGeAlD
Fosinopril—ACE—head—melanoma	0.000848	0.0217	CbGeAlD
Fosinopril—SLC15A2—head—melanoma	0.00074	0.0189	CbGeAlD
Fosinopril—Mitiglinide—PPARG—melanoma	0.0007	0.109	CrCbGaD
Fosinopril—ACE—lymph node—melanoma	0.000594	0.0152	CbGeAlD
Fosinopril—SLC15A2—lymph node—melanoma	0.000518	0.0132	CbGeAlD
Fosinopril—Flushing—Dactinomycin—melanoma	0.000333	0.00237	CcSEcCtD
Fosinopril—Hypersensitivity—Vemurafenib—melanoma	0.000333	0.00237	CcSEcCtD
Fosinopril—Oedema peripheral—Carmustine—melanoma	0.000331	0.00236	CcSEcCtD
Fosinopril—Menopausal symptoms—Docetaxel—melanoma	0.000331	0.00236	CcSEcCtD
Fosinopril—Dermatitis bullous—Docetaxel—melanoma	0.000327	0.00233	CcSEcCtD
Fosinopril—Haemoglobin—Temozolomide—melanoma	0.000326	0.00232	CcSEcCtD
Fosinopril—Haemorrhage—Temozolomide—melanoma	0.000325	0.00231	CcSEcCtD
Fosinopril—Hepatitis—Temozolomide—melanoma	0.000325	0.00231	CcSEcCtD
Fosinopril—Asthenia—Vemurafenib—melanoma	0.000324	0.00231	CcSEcCtD
Fosinopril—Visual impairment—Carmustine—melanoma	0.000324	0.00231	CcSEcCtD
Fosinopril—Hallucination—Temozolomide—melanoma	0.000323	0.0023	CcSEcCtD
Fosinopril—Hypoaesthesia—Temozolomide—melanoma	0.000323	0.0023	CcSEcCtD
Fosinopril—Pharyngitis—Temozolomide—melanoma	0.000322	0.00229	CcSEcCtD
Fosinopril—Chills—Dactinomycin—melanoma	0.000322	0.00229	CcSEcCtD
Fosinopril—Oedema peripheral—Temozolomide—melanoma	0.00032	0.00228	CcSEcCtD
Fosinopril—Pruritus—Vemurafenib—melanoma	0.000319	0.00227	CcSEcCtD
Fosinopril—Hyponatraemia—Docetaxel—melanoma	0.000313	0.00223	CcSEcCtD
Fosinopril—Visual impairment—Temozolomide—melanoma	0.000313	0.00223	CcSEcCtD
Fosinopril—Flushing—Carmustine—melanoma	0.000312	0.00222	CcSEcCtD
Fosinopril—Ill-defined disorder—Bleomycin—melanoma	0.000311	0.00221	CcSEcCtD
Fosinopril—Anaemia—Bleomycin—melanoma	0.00031	0.00221	CcSEcCtD
Fosinopril—Diarrhoea—Vemurafenib—melanoma	0.000309	0.0022	CcSEcCtD
Fosinopril—Erythema multiforme—Temozolomide—melanoma	0.000307	0.00219	CcSEcCtD
Fosinopril—Tinnitus—Temozolomide—melanoma	0.000303	0.00216	CcSEcCtD
Fosinopril—Malaise—Bleomycin—melanoma	0.000302	0.00215	CcSEcCtD
Fosinopril—Flushing—Temozolomide—melanoma	0.000301	0.00215	CcSEcCtD
Fosinopril—Arrhythmia—Carmustine—melanoma	0.0003	0.00214	CcSEcCtD
Fosinopril—Leukopenia—Bleomycin—melanoma	0.0003	0.00214	CcSEcCtD
Fosinopril—Dizziness—Vemurafenib—melanoma	0.000299	0.00213	CcSEcCtD
Fosinopril—Cough—Bleomycin—melanoma	0.000292	0.00208	CcSEcCtD
Fosinopril—Chills—Temozolomide—melanoma	0.000291	0.00207	CcSEcCtD
Fosinopril—Ill-defined disorder—Dactinomycin—melanoma	0.00029	0.00206	CcSEcCtD
Fosinopril—Anaemia—Dactinomycin—melanoma	0.000289	0.00206	CcSEcCtD
Fosinopril—Vomiting—Vemurafenib—melanoma	0.000287	0.00204	CcSEcCtD
Fosinopril—Dry skin—Docetaxel—melanoma	0.000286	0.00204	CcSEcCtD
Fosinopril—Chest pain—Bleomycin—melanoma	0.000285	0.00203	CcSEcCtD
Fosinopril—Myalgia—Bleomycin—melanoma	0.000285	0.00203	CcSEcCtD
Fosinopril—Orthostatic hypotension—Docetaxel—melanoma	0.000285	0.00203	CcSEcCtD
Fosinopril—Abdominal pain upper—Docetaxel—melanoma	0.000285	0.00203	CcSEcCtD
Fosinopril—Rash—Vemurafenib—melanoma	0.000285	0.00203	CcSEcCtD
Fosinopril—Dermatitis—Vemurafenib—melanoma	0.000284	0.00202	CcSEcCtD
Fosinopril—Headache—Vemurafenib—melanoma	0.000283	0.00201	CcSEcCtD
Fosinopril—Breast disorder—Docetaxel—melanoma	0.000282	0.00201	CcSEcCtD
Fosinopril—Discomfort—Bleomycin—melanoma	0.000282	0.00201	CcSEcCtD
Fosinopril—Malaise—Dactinomycin—melanoma	0.000282	0.00201	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000281	0.002	CcSEcCtD
Fosinopril—Cramp muscle—Docetaxel—melanoma	0.000281	0.002	CcSEcCtD
Fosinopril—Leukopenia—Dactinomycin—melanoma	0.00028	0.00199	CcSEcCtD
Fosinopril—Dysgeusia—Temozolomide—melanoma	0.000277	0.00197	CcSEcCtD
Fosinopril—Confusional state—Bleomycin—melanoma	0.000276	0.00196	CcSEcCtD
Fosinopril—Vision blurred—Carmustine—melanoma	0.000276	0.00196	CcSEcCtD
Fosinopril—Tremor—Carmustine—melanoma	0.000274	0.00195	CcSEcCtD
Fosinopril—Oedema—Bleomycin—melanoma	0.000274	0.00195	CcSEcCtD
Fosinopril—Anaphylactic shock—Bleomycin—melanoma	0.000274	0.00195	CcSEcCtD
Fosinopril—Infection—Bleomycin—melanoma	0.000272	0.00193	CcSEcCtD
Fosinopril—Anaemia—Carmustine—melanoma	0.00027	0.00193	CcSEcCtD
Fosinopril—Dysphagia—Docetaxel—melanoma	0.00027	0.00192	CcSEcCtD
Fosinopril—Agitation—Carmustine—melanoma	0.000269	0.00191	CcSEcCtD
Fosinopril—Nausea—Vemurafenib—melanoma	0.000268	0.00191	CcSEcCtD
Fosinopril—Thrombocytopenia—Bleomycin—melanoma	0.000268	0.00191	CcSEcCtD
Fosinopril—Vision blurred—Temozolomide—melanoma	0.000266	0.0019	CcSEcCtD
Fosinopril—Myalgia—Dactinomycin—melanoma	0.000266	0.00189	CcSEcCtD
Fosinopril—Bronchospasm—Docetaxel—melanoma	0.000265	0.00189	CcSEcCtD
Fosinopril—Tremor—Temozolomide—melanoma	0.000265	0.00189	CcSEcCtD
Fosinopril—Discomfort—Dactinomycin—melanoma	0.000263	0.00187	CcSEcCtD
Fosinopril—Angina pectoris—Docetaxel—melanoma	0.000263	0.00187	CcSEcCtD
Fosinopril—Ill-defined disorder—Temozolomide—melanoma	0.000262	0.00187	CcSEcCtD
Fosinopril—Leukopenia—Carmustine—melanoma	0.000262	0.00186	CcSEcCtD
Fosinopril—Anaemia—Temozolomide—melanoma	0.000261	0.00186	CcSEcCtD
Fosinopril—Anorexia—Bleomycin—melanoma	0.000261	0.00186	CcSEcCtD
Fosinopril—Agitation—Temozolomide—melanoma	0.00026	0.00185	CcSEcCtD
Fosinopril—Angioedema—Temozolomide—melanoma	0.000258	0.00184	CcSEcCtD
Fosinopril—Pancytopenia—Docetaxel—melanoma	0.000256	0.00182	CcSEcCtD
Fosinopril—Hypotension—Bleomycin—melanoma	0.000256	0.00182	CcSEcCtD
Fosinopril—Lisinopril—ABCB1—melanoma	0.000255	0.0396	CrCbGaD
Fosinopril—Cilazapril—ABCB1—melanoma	0.000255	0.0396	CrCbGaD
Fosinopril—Oedema—Dactinomycin—melanoma	0.000255	0.00182	CcSEcCtD
Fosinopril—Malaise—Temozolomide—melanoma	0.000255	0.00182	CcSEcCtD
Fosinopril—Vertigo—Temozolomide—melanoma	0.000254	0.00181	CcSEcCtD
Fosinopril—Infection—Dactinomycin—melanoma	0.000253	0.0018	CcSEcCtD
Fosinopril—Leukopenia—Temozolomide—melanoma	0.000253	0.0018	CcSEcCtD
Fosinopril—Hypertension—Carmustine—melanoma	0.000253	0.0018	CcSEcCtD
Fosinopril—Neutropenia—Docetaxel—melanoma	0.000252	0.0018	CcSEcCtD
Fosinopril—Palpitations—Temozolomide—melanoma	0.00025	0.00178	CcSEcCtD
Fosinopril—Thrombocytopenia—Dactinomycin—melanoma	0.00025	0.00178	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000249	0.00177	CcSEcCtD
Fosinopril—Chest pain—Carmustine—melanoma	0.000249	0.00177	CcSEcCtD
Fosinopril—Myalgia—Carmustine—melanoma	0.000249	0.00177	CcSEcCtD
Fosinopril—Cough—Temozolomide—melanoma	0.000247	0.00176	CcSEcCtD
Fosinopril—Paraesthesia—Bleomycin—melanoma	0.000246	0.00175	CcSEcCtD
Fosinopril—Weight increased—Docetaxel—melanoma	0.000246	0.00175	CcSEcCtD
Fosinopril—Weight decreased—Docetaxel—melanoma	0.000244	0.00174	CcSEcCtD
Fosinopril—Hypertension—Temozolomide—melanoma	0.000244	0.00174	CcSEcCtD
Fosinopril—Dyspnoea—Bleomycin—melanoma	0.000244	0.00174	CcSEcCtD
Fosinopril—Anorexia—Dactinomycin—melanoma	0.000243	0.00173	CcSEcCtD
Fosinopril—Pneumonia—Docetaxel—melanoma	0.000242	0.00172	CcSEcCtD
Fosinopril—Confusional state—Carmustine—melanoma	0.000241	0.00171	CcSEcCtD
Fosinopril—Myalgia—Temozolomide—melanoma	0.000241	0.00171	CcSEcCtD
Fosinopril—Arthralgia—Temozolomide—melanoma	0.000241	0.00171	CcSEcCtD
Fosinopril—Oedema—Carmustine—melanoma	0.000239	0.0017	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000239	0.0017	CcSEcCtD
Fosinopril—Discomfort—Temozolomide—melanoma	0.000238	0.00169	CcSEcCtD
Fosinopril—Decreased appetite—Bleomycin—melanoma	0.000238	0.00169	CcSEcCtD
Fosinopril—Infection—Carmustine—melanoma	0.000237	0.00169	CcSEcCtD
Fosinopril—Acute coronary syndrome—Docetaxel—melanoma	0.000237	0.00169	CcSEcCtD
Fosinopril—Renal failure—Docetaxel—melanoma	0.000237	0.00168	CcSEcCtD
Fosinopril—Neuropathy peripheral—Docetaxel—melanoma	0.000236	0.00168	CcSEcCtD
Fosinopril—Myocardial infarction—Docetaxel—melanoma	0.000236	0.00168	CcSEcCtD
Fosinopril—Dry mouth—Temozolomide—melanoma	0.000235	0.00168	CcSEcCtD
Fosinopril—Jaundice—Docetaxel—melanoma	0.000235	0.00167	CcSEcCtD
Fosinopril—Pain—Bleomycin—melanoma	0.000234	0.00167	CcSEcCtD
Fosinopril—Thrombocytopenia—Carmustine—melanoma	0.000234	0.00166	CcSEcCtD
Fosinopril—Tachycardia—Carmustine—melanoma	0.000233	0.00166	CcSEcCtD
Fosinopril—Confusional state—Temozolomide—melanoma	0.000233	0.00166	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000232	0.00165	CcSEcCtD
Fosinopril—Anaphylactic shock—Temozolomide—melanoma	0.000231	0.00164	CcSEcCtD
Fosinopril—Oedema—Temozolomide—melanoma	0.000231	0.00164	CcSEcCtD
Fosinopril—Infection—Temozolomide—melanoma	0.000229	0.00163	CcSEcCtD
Fosinopril—Anorexia—Carmustine—melanoma	0.000228	0.00162	CcSEcCtD
Fosinopril—Epistaxis—Docetaxel—melanoma	0.000227	0.00162	CcSEcCtD
Fosinopril—Thrombocytopenia—Temozolomide—melanoma	0.000226	0.00161	CcSEcCtD
Fosinopril—Feeling abnormal—Bleomycin—melanoma	0.000225	0.0016	CcSEcCtD
Fosinopril—Agranulocytosis—Docetaxel—melanoma	0.000225	0.0016	CcSEcCtD
Fosinopril—Hypotension—Carmustine—melanoma	0.000223	0.00159	CcSEcCtD
Fosinopril—Hyperhidrosis—Temozolomide—melanoma	0.000223	0.00159	CcSEcCtD
Fosinopril—Decreased appetite—Dactinomycin—melanoma	0.000222	0.00158	CcSEcCtD
Fosinopril—Fatigue—Dactinomycin—melanoma	0.00022	0.00157	CcSEcCtD
Fosinopril—Anorexia—Temozolomide—melanoma	0.00022	0.00157	CcSEcCtD
Fosinopril—Pain—Dactinomycin—melanoma	0.000218	0.00155	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Carmustine—melanoma	0.000218	0.00155	CcSEcCtD
Fosinopril—Urticaria—Bleomycin—melanoma	0.000217	0.00155	CcSEcCtD
Fosinopril—Haemoglobin—Docetaxel—melanoma	0.000217	0.00155	CcSEcCtD
Fosinopril—Rhinitis—Docetaxel—melanoma	0.000217	0.00154	CcSEcCtD
Fosinopril—Body temperature increased—Bleomycin—melanoma	0.000216	0.00154	CcSEcCtD
Fosinopril—Haemorrhage—Docetaxel—melanoma	0.000216	0.00154	CcSEcCtD
Fosinopril—Hepatitis—Docetaxel—melanoma	0.000216	0.00154	CcSEcCtD
Fosinopril—Insomnia—Carmustine—melanoma	0.000216	0.00154	CcSEcCtD
Fosinopril—Hypoaesthesia—Docetaxel—melanoma	0.000215	0.00153	CcSEcCtD
Fosinopril—Paraesthesia—Carmustine—melanoma	0.000214	0.00153	CcSEcCtD
Fosinopril—Pharyngitis—Docetaxel—melanoma	0.000214	0.00153	CcSEcCtD
Fosinopril—Dyspnoea—Carmustine—melanoma	0.000213	0.00152	CcSEcCtD
Fosinopril—Oedema peripheral—Docetaxel—melanoma	0.000213	0.00151	CcSEcCtD
Fosinopril—Somnolence—Carmustine—melanoma	0.000212	0.00151	CcSEcCtD
Fosinopril—Feeling abnormal—Dactinomycin—melanoma	0.00021	0.0015	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Temozolomide—melanoma	0.00021	0.0015	CcSEcCtD
Fosinopril—Insomnia—Temozolomide—melanoma	0.000209	0.00149	CcSEcCtD
Fosinopril—Gastrointestinal pain—Dactinomycin—melanoma	0.000209	0.00149	CcSEcCtD
Fosinopril—Visual impairment—Docetaxel—melanoma	0.000208	0.00148	CcSEcCtD
Fosinopril—Decreased appetite—Carmustine—melanoma	0.000208	0.00148	CcSEcCtD
Fosinopril—Paraesthesia—Temozolomide—melanoma	0.000207	0.00148	CcSEcCtD
Fosinopril—Dyspnoea—Temozolomide—melanoma	0.000206	0.00146	CcSEcCtD
Fosinopril—Somnolence—Temozolomide—melanoma	0.000205	0.00146	CcSEcCtD
Fosinopril—Erythema multiforme—Docetaxel—melanoma	0.000204	0.00145	CcSEcCtD
Fosinopril—Pain—Carmustine—melanoma	0.000204	0.00145	CcSEcCtD
Fosinopril—Constipation—Carmustine—melanoma	0.000204	0.00145	CcSEcCtD
Fosinopril—Dyspepsia—Temozolomide—melanoma	0.000203	0.00145	CcSEcCtD
Fosinopril—Abdominal pain—Dactinomycin—melanoma	0.000202	0.00144	CcSEcCtD
Fosinopril—Body temperature increased—Dactinomycin—melanoma	0.000202	0.00144	CcSEcCtD
Fosinopril—Hypersensitivity—Bleomycin—melanoma	0.000202	0.00143	CcSEcCtD
Fosinopril—Decreased appetite—Temozolomide—melanoma	0.000201	0.00143	CcSEcCtD
Fosinopril—Flushing—Docetaxel—melanoma	0.0002	0.00143	CcSEcCtD
Fosinopril—Fatigue—Temozolomide—melanoma	0.000199	0.00142	CcSEcCtD
Fosinopril—Pain—Temozolomide—melanoma	0.000197	0.0014	CcSEcCtD
Fosinopril—Constipation—Temozolomide—melanoma	0.000197	0.0014	CcSEcCtD
Fosinopril—Feeling abnormal—Carmustine—melanoma	0.000197	0.0014	CcSEcCtD
Fosinopril—Asthenia—Bleomycin—melanoma	0.000196	0.0014	CcSEcCtD
Fosinopril—Gastrointestinal pain—Carmustine—melanoma	0.000195	0.00139	CcSEcCtD
Fosinopril—Chills—Docetaxel—melanoma	0.000194	0.00138	CcSEcCtD
Fosinopril—Pruritus—Bleomycin—melanoma	0.000194	0.00138	CcSEcCtD
Fosinopril—Arrhythmia—Docetaxel—melanoma	0.000193	0.00137	CcSEcCtD
Fosinopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000191	0.053	CbGpPWpGaD
Fosinopril—Feeling abnormal—Temozolomide—melanoma	0.00019	0.00135	CcSEcCtD
Fosinopril—Body temperature increased—Carmustine—melanoma	0.000189	0.00134	CcSEcCtD
Fosinopril—Abdominal pain—Carmustine—melanoma	0.000189	0.00134	CcSEcCtD
Fosinopril—Gastrointestinal pain—Temozolomide—melanoma	0.000189	0.00134	CcSEcCtD
Fosinopril—Hypersensitivity—Dactinomycin—melanoma	0.000188	0.00134	CcSEcCtD
Fosinopril—Enalapril—ABCB1—melanoma	0.000187	0.0291	CrCbGaD
Fosinopril—Dysgeusia—Docetaxel—melanoma	0.000184	0.00131	CcSEcCtD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000184	0.0511	CbGpPWpGaD
Fosinopril—Urticaria—Temozolomide—melanoma	0.000183	0.00131	CcSEcCtD
Fosinopril—Asthenia—Dactinomycin—melanoma	0.000183	0.0013	CcSEcCtD
Fosinopril—Body temperature increased—Temozolomide—melanoma	0.000182	0.0013	CcSEcCtD
Fosinopril—Abdominal pain—Temozolomide—melanoma	0.000182	0.0013	CcSEcCtD
Fosinopril—Muscle spasms—Docetaxel—melanoma	0.000181	0.00129	CcSEcCtD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000177	0.0492	CbGpPWpGaD
Fosinopril—Hypersensitivity—Carmustine—melanoma	0.000176	0.00125	CcSEcCtD
Fosinopril—Diarrhoea—Dactinomycin—melanoma	0.000175	0.00124	CcSEcCtD
Fosinopril—Vomiting—Bleomycin—melanoma	0.000174	0.00124	CcSEcCtD
Fosinopril—Anaemia—Docetaxel—melanoma	0.000174	0.00124	CcSEcCtD
Fosinopril—Rash—Bleomycin—melanoma	0.000172	0.00123	CcSEcCtD
Fosinopril—Dermatitis—Bleomycin—melanoma	0.000172	0.00123	CcSEcCtD
Fosinopril—Asthenia—Carmustine—melanoma	0.000171	0.00122	CcSEcCtD
Fosinopril—Hypersensitivity—Temozolomide—melanoma	0.00017	0.00121	CcSEcCtD
Fosinopril—Syncope—Docetaxel—melanoma	0.000169	0.0012	CcSEcCtD
Fosinopril—Leukopenia—Docetaxel—melanoma	0.000168	0.0012	CcSEcCtD
Fosinopril—Palpitations—Docetaxel—melanoma	0.000166	0.00118	CcSEcCtD
Fosinopril—Asthenia—Temozolomide—melanoma	0.000166	0.00118	CcSEcCtD
Fosinopril—Loss of consciousness—Docetaxel—melanoma	0.000165	0.00118	CcSEcCtD
Fosinopril—Cough—Docetaxel—melanoma	0.000164	0.00117	CcSEcCtD
Fosinopril—Diarrhoea—Carmustine—melanoma	0.000163	0.00116	CcSEcCtD
Fosinopril—Pruritus—Temozolomide—melanoma	0.000163	0.00116	CcSEcCtD
Fosinopril—Nausea—Bleomycin—melanoma	0.000162	0.00116	CcSEcCtD
Fosinopril—Hypertension—Docetaxel—melanoma	0.000162	0.00116	CcSEcCtD
Fosinopril—Vomiting—Dactinomycin—melanoma	0.000162	0.00115	CcSEcCtD
Fosinopril—Rash—Dactinomycin—melanoma	0.000161	0.00115	CcSEcCtD
Fosinopril—Arthralgia—Docetaxel—melanoma	0.00016	0.00114	CcSEcCtD
Fosinopril—Myalgia—Docetaxel—melanoma	0.00016	0.00114	CcSEcCtD
Fosinopril—Chest pain—Docetaxel—melanoma	0.00016	0.00114	CcSEcCtD
Fosinopril—Dizziness—Carmustine—melanoma	0.000158	0.00112	CcSEcCtD
Fosinopril—Diarrhoea—Temozolomide—melanoma	0.000158	0.00112	CcSEcCtD
Fosinopril—Dry mouth—Docetaxel—melanoma	0.000157	0.00111	CcSEcCtD
Fosinopril—Confusional state—Docetaxel—melanoma	0.000155	0.0011	CcSEcCtD
Fosinopril—Oedema—Docetaxel—melanoma	0.000153	0.00109	CcSEcCtD
Fosinopril—Anaphylactic shock—Docetaxel—melanoma	0.000153	0.00109	CcSEcCtD
Fosinopril—Dizziness—Temozolomide—melanoma	0.000153	0.00109	CcSEcCtD
Fosinopril—Infection—Docetaxel—melanoma	0.000152	0.00109	CcSEcCtD
Fosinopril—Vomiting—Carmustine—melanoma	0.000152	0.00108	CcSEcCtD
Fosinopril—Nausea—Dactinomycin—melanoma	0.000152	0.00108	CcSEcCtD
Fosinopril—Shock—Docetaxel—melanoma	0.000151	0.00107	CcSEcCtD
Fosinopril—Rash—Carmustine—melanoma	0.000151	0.00107	CcSEcCtD
Fosinopril—Dermatitis—Carmustine—melanoma	0.00015	0.00107	CcSEcCtD
Fosinopril—Thrombocytopenia—Docetaxel—melanoma	0.00015	0.00107	CcSEcCtD
Fosinopril—Tachycardia—Docetaxel—melanoma	0.00015	0.00107	CcSEcCtD
Fosinopril—Headache—Carmustine—melanoma	0.00015	0.00106	CcSEcCtD
Fosinopril—Vomiting—Temozolomide—melanoma	0.000147	0.00104	CcSEcCtD
Fosinopril—Anorexia—Docetaxel—melanoma	0.000146	0.00104	CcSEcCtD
Fosinopril—Rash—Temozolomide—melanoma	0.000145	0.00104	CcSEcCtD
Fosinopril—Dermatitis—Temozolomide—melanoma	0.000145	0.00103	CcSEcCtD
Fosinopril—Headache—Temozolomide—melanoma	0.000145	0.00103	CcSEcCtD
Fosinopril—Hypotension—Docetaxel—melanoma	0.000143	0.00102	CcSEcCtD
Fosinopril—Nausea—Carmustine—melanoma	0.000142	0.00101	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Docetaxel—melanoma	0.00014	0.000995	CcSEcCtD
Fosinopril—Insomnia—Docetaxel—melanoma	0.000139	0.000988	CcSEcCtD
Fosinopril—Paraesthesia—Docetaxel—melanoma	0.000138	0.000981	CcSEcCtD
Fosinopril—Nausea—Temozolomide—melanoma	0.000137	0.000976	CcSEcCtD
Fosinopril—Dyspnoea—Docetaxel—melanoma	0.000137	0.000974	CcSEcCtD
Fosinopril—Somnolence—Docetaxel—melanoma	0.000136	0.000971	CcSEcCtD
Fosinopril—Dyspepsia—Docetaxel—melanoma	0.000135	0.000962	CcSEcCtD
Fosinopril—Decreased appetite—Docetaxel—melanoma	0.000133	0.00095	CcSEcCtD
Fosinopril—Fatigue—Docetaxel—melanoma	0.000132	0.000942	CcSEcCtD
Fosinopril—Pain—Docetaxel—melanoma	0.000131	0.000934	CcSEcCtD
Fosinopril—Constipation—Docetaxel—melanoma	0.000131	0.000934	CcSEcCtD
Fosinopril—Feeling abnormal—Docetaxel—melanoma	0.000126	0.0009	CcSEcCtD
Fosinopril—Gastrointestinal pain—Docetaxel—melanoma	0.000125	0.000893	CcSEcCtD
Fosinopril—Body temperature increased—Docetaxel—melanoma	0.000121	0.000864	CcSEcCtD
Fosinopril—Abdominal pain—Docetaxel—melanoma	0.000121	0.000864	CcSEcCtD
Fosinopril—Hypersensitivity—Docetaxel—melanoma	0.000113	0.000805	CcSEcCtD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000112	0.0312	CbGpPWpGaD
Fosinopril—Asthenia—Docetaxel—melanoma	0.00011	0.000784	CcSEcCtD
Fosinopril—Pruritus—Docetaxel—melanoma	0.000109	0.000773	CcSEcCtD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000108	0.0301	CbGpPWpGaD
Fosinopril—Diarrhoea—Docetaxel—melanoma	0.000105	0.000747	CcSEcCtD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000104	0.029	CbGpPWpGaD
Fosinopril—Dizziness—Docetaxel—melanoma	0.000101	0.000722	CcSEcCtD
Fosinopril—Vomiting—Docetaxel—melanoma	9.76e-05	0.000695	CcSEcCtD
Fosinopril—Rash—Docetaxel—melanoma	9.68e-05	0.000689	CcSEcCtD
Fosinopril—Dermatitis—Docetaxel—melanoma	9.67e-05	0.000688	CcSEcCtD
Fosinopril—Headache—Docetaxel—melanoma	9.61e-05	0.000684	CcSEcCtD
Fosinopril—Nausea—Docetaxel—melanoma	9.11e-05	0.000649	CcSEcCtD
Fosinopril—ACE—Peptide hormone metabolism—PAX6—melanoma	9.03e-05	0.0251	CbGpPWpGaD
Fosinopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	7.92e-05	0.022	CbGpPWpGaD
Fosinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	7.35e-05	0.0204	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ADAMTS20—melanoma	5.57e-05	0.0155	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PIGU—melanoma	5.57e-05	0.0155	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ARL2—melanoma	5.09e-05	0.0141	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	5.04e-05	0.014	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	5.02e-05	0.0139	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	4.84e-05	0.0134	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	4.68e-05	0.013	CbGpPWpGaD
Fosinopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	4.66e-05	0.013	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	4.66e-05	0.0129	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	4.56e-05	0.0127	CbGpPWpGaD
Fosinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	4.33e-05	0.012	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	4.23e-05	0.0117	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—IGF1—melanoma	4.11e-05	0.0114	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—SLC17A5—melanoma	3.71e-05	0.0103	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—ADAMTS13—melanoma	3.59e-05	0.00996	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	3.5e-05	0.00971	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	3.24e-05	0.00901	CbGpPWpGaD
Fosinopril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	3.05e-05	0.00847	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—RPS3—melanoma	2.67e-05	0.00743	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	2.55e-05	0.00708	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.46e-05	0.00683	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.37e-05	0.00658	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	2.32e-05	0.00643	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.15e-05	0.00597	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.08e-05	0.00579	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.93e-05	0.00537	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—PAX6—melanoma	1.7e-05	0.00474	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—HSPA5—melanoma	1.64e-05	0.00455	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.06e-05	0.00294	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	9.94e-06	0.00276	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	9.83e-06	0.00273	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—MMP1—melanoma	9.7e-06	0.0027	CbGpPWpGaD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	9.23e-06	0.00256	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	8.07e-06	0.00224	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—IGF1—melanoma	7.76e-06	0.00216	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—MMP2—melanoma	7.51e-06	0.00209	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	7.49e-06	0.00208	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CXCL8—melanoma	6.24e-06	0.00173	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—CTNNB1—melanoma	5.76e-06	0.0016	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	5.05e-06	0.0014	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	4.69e-06	0.0013	CbGpPWpGaD
